Security Benefit Life Insurance Company’s FinServ Acquisition Corp. II Warrant FSRXW Stock Holding History

Security Benefit Life Insurance Company’s Portfolio FSRXW Stock Details FSRXW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-100,000	Closed	-$3.2K	–	48
2023 Q3	$3.2K	Hold	100,000	–	–	﹤0.01%	41
2023 Q2	$2.15K	Hold	100,000	–	–	﹤0.01%	50
2023 Q1	$3.7K	Hold	100,000	–	–	﹤0.01%	56
2022 Q4	$510	Hold	100,000	–	–	﹤0.01%	73
2022 Q3	$3K	Hold	100,000	–	–	﹤0.01%	80
2022 Q2	$16K	Buy	+100,000	New	+$26.1K	﹤0.01%	66
2022 Q1	–	Sell	-100,000	Closed	-$62K	–	50
2021 Q4	$62K	Hold	100,000	–	–	﹤0.01%	68
2021 Q3	$85K	Hold	100,000	–	–	0.01%	145
2021 Q2	$120K	Buy	+100,000	New	+$91.9K	0.01%	121

Other funds holding FSRXW

Altshuler Shaham Tel Aviv, Israel $5.54B AUM 44.68% 1-Year Est. Return

Security Benefit Life Insurance Company's FSRXW Position: Q4 2023 in Review

Security Benefit Life Insurance Company sold out of FinServ Acquisition Corp. II Warrant (FSRXW) in Q4 2023, closing a stake of 100,000 shares — an estimated $3.2K sold.

Security Benefit Life Insurance Company first reported a position in FSRXW in Q2 2021 and held it in 9 quarters. The position peaked at $120K in Q2 2021. 1 fund tracked by Wall St. Rank holds FSRXW as of Q4 2023.

Security Benefit Life Insurance Company reported no remaining FinServ Acquisition Corp. II Warrant position as of Q4 2023 after selling out during the quarter.
Security Benefit Life Insurance Company sold 100,000 FinServ Acquisition Corp. II Warrant shares in Q4 2023, an estimated $3.2K.
Security Benefit Life Insurance Company first reported a position in FinServ Acquisition Corp. II Warrant in Q2 2021 and held it in 9 quarters.
Security Benefit Life Insurance Company's FinServ Acquisition Corp. II Warrant position peaked at $120K in Q2 2021.
1 fund tracked by Wall St. Rank held FinServ Acquisition Corp. II Warrant as of Q4 2023.

Based on Security Benefit Life Insurance Company's 13F filing for Q4 2023, filed 9 Feb 2024.